100
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Pro-inflammatory interleukins in patients operated on for proximal femur fracture

, , , , &
Pages 158-163 | Received 07 Nov 2009, Accepted 22 Dec 2009, Published online: 11 Mar 2010

References

  • Parker MJ, Palmer CR. Prediction of rehabilitation after hip fracture. Age Ageing 1995;24:96–8.
  • Broos PL, van Haaften KI, van Leeuwen PA, Vandeputte JH, Stappaerts KH. Hip fractures in the elderly: mortality, functional results and probability of returning home. Ned Tijdschr Geneeskd 1990;134:957–61.
  • Bannister GC, Gibson AG, Ackroyd CE, Newman JH. The fixation and prognosis of trochanteric fractures. A randomized prospective controlled trial. Clin Orthop 1990;254:242–46.
  • Sernbo I, Johnell O. Consequences of a hip fracture: a prospective study over 1 year. Osteoporos Int 1993;3:148–53.
  • Todd CJ, Freeman CJ, Camilleri-Ferrante C, Palmer CR, Hyder A, Laxton CE, Parker MJ, Payne BV, Rushton N. Differences in mortality after fracture of hip: the east Anglian audit. BMJ 1995; 310:904–8.
  • Advocaat C, Bautz-Holter E. Prognosis one year after hip fracture. Tidsskr Nor Laegeforen 1997;117:3801–3.
  • Russel PA, Parker MJ. Functional outcome after hip fracture. A 1-year prospective outcome study of 275 patients. Injury 2003;34:529–32.
  • Lund E. Mortality resulting from femoral neck fractures in Norway 1980–94. Tidsskr Nor Laegeforen 1998;118: 2764–6.
  • Lie SA, Engesaeter LB, Havelin LI, Furnes O, Vollset SE. Early postoperative mortality after 67,548 total hip replacements: causes of death and thromboprophylaxis in 68 hospitals in Norway from 1987 to 1999. Acta Orthop Scand 2002;73:392–9.
  • Kitamura S, Hasegawa Y, Suzuki S, Sasaki R, Iwata H, Wingstrand H, Thorngren KG. Functional outcome after hip fracture in Japan. Clin Orthop Relate Res 1998;348:29–36.
  • Hedlund R, Lindgren U, Ahlbom A. Age- and sex-specific incidence of femoral neck and trochanteric fractures. An analysis based on 20,538 fractures in Stockholm County, Sweden, 1972–1981. Clin Orthop 1987;222:132–9.
  • Luthje P. Fractures of the proximal femur in Finland in 1980. Ann Chir Gynaecol 1983;72:282–6.
  • Grion AM, Gallo U, Bano F, Ragazzi M, Cestrone Adriano, Orsini Arturo, Salomoni M. Difference in mortality after hip fracture is associated with postdischarge prescription of antithrombotic prophylaxis: a case-control study. Clin Appl Thromb Hemost 2002;8:143–6.
  • Anderson GH, Raymakers R, Gregg PJ. The incidence of proximal femoral fractures in an English county. J Bone Joint Surg Br 1993;75:441–4.
  • Walloe A, Andersson S, Herrlin K, Lindgren L. Incidence and stability of trochanteric femoral fractures. Acta Orthop Scand 1983;54:622–6.
  • Falch JA, Ilebekk A, Slungaard U. Epidemiology of hip fractures in Norway. Acta Orthop Scand 1985;56:12–6.
  • Bulajic-Kopjar M, Wiik J, Nordhagen R. Regional differences in the incidence of femoral neck fractures in Norway. Tidsskr Nor Laegeforen 1998;118:30–3.
  • Zuckerman JD. Hip fracture. N Engl J Med 1996;334: 1519–25.
  • Borgquist L, Nordell E, Jarnlo GB, Stromqvist B, Wingstrand H. Thorngren KG. Hip fractures in primary health care. Evaluation of a rehabilitation programme. Scand J Prim Health Care 1990;8:139–44.
  • Falch JA, Meyer HE. Osteoporosis and fractures in Norway. Occurrence and risk factors. Tidsskr Nor Laegeforen 1998; 118:568–72.
  • Fox HJ, Hughes SJ, Pooler J, Prothero D, Bannister GC. Length of hospital stay and outcome after femoral neck fracture: a prospective study comparing the performance of two hospitals. Injury 1993;24:464–6.
  • Gilchrist WJ, Newman RJ, Hamblen DL, Williams BO. Prospective randomised study of an orthopaedic geriatric inpatient service. BMJ 1988;297:1116–8.
  • Majno G, Palade GE. Studies on inflammation. 1. The effect of histamine and serotonin on vascular permeability: an electron microscopic study. J Biophys Biochem Cytol 1961;11:571–605.
  • Grega GJ, Dobbins DE, Scott JB, Haddy FJ. Effects of histamin and increased venous pressure on transmicrovascular protein transposrt. Microvasc Res 1979;18:95–104.
  • Korthuis RJ, Wang CY, Spielman WS. Transient effects of histamine on the capillary filtration coefficient. Microvasc Res 1984;28:322–44.
  • Pape HC, Grimme K, Van Griensven M, Sott AH, Giannoudis P, Morley J, Roise O, Ellingsen E, Hildebrand F, Wiese B, Krettek C, EPOFF Study Group. Impact of intramedullary instrumentation versus damage control for femoral fractures on immunoinflammatory parameters: prospective randomized analysis by the EPOFF Study Group. J Trauma 2003;55:7–13.
  • Müller ME, Nazarian S, Koch P, Koch P, Schatzker J. The AO classification of fractures of long bones. Berlin: Springer-Verlag; 1990.
  • Dunki Jacobs PB, Raaymakers ELFB, Giebel G. Introduction to the problem and classification of proximal femoral fractures. Proximal femoral fractures: Operative techniques and complications. Vol. 1. London, England: Medical Press, Ltd., 1993. 1–42.
  • Kazmi SS, Stranden E, Kroese AJ, Slagsvold CE, Diep LM, Stromsoe K, Jorgensen JJ. Edema in the lower limb of patients operated on for proximal femoral fractures. J Trauma 2007;62:701–7.
  • Stranden E. A comparison between surface measurements and water displacement volumetry for the quantification of leg edema. J Oslo City Hosp 1981;31:153–5.
  • Strandness DE Jr. Diagnostic approaches for detecting deep vein thrombosis. Am J Card Imaging 1994;8:13–7.
  • Barnes RW, Collicott PE, Mozersky DJ, Summer DS, Strandness DE Jr. Noninvasive quantitation of maximum venous outflow in acute thrombophlebitis. Surgery 1972;72:971–9.
  • Keel M, Trentz O. Pathophysiology of polytrauma. Injury 2005;36:691–9.
  • Martins C, Boisson C, Haccoun M, Thomachot L, Mege JL. Patterns of cytokine evolution (TNF-α and IL-6) after septic shock, hemorrhage shock, and severe trauma. Crit Care Med 1997;25:1813–9.
  • Miller RR, Cappola AR, Shardell MD, Hawkes WG, Yu-Yahiro JA, Hebel JR, Magaziner J. Persistent changes in interleukin-6 and lower extremity function following hip fractures. J Gerontol A Biol Sci Med Sci 2006;61:1053–8.
  • Lal R, O'Brien S, Maushouri T, Rogers A, Kantarjian H, Keating M, Albitar M. Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia. Cancer 2002;95:1071–5.
  • Musselman DL, Miller AH, Porter MR, Manatunga A, Gao F, Penna S, Pearce BD, Landry J, Glover S, McDaniel JS, Nemeroff CB. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry 2001;158:1252–7.
  • Boekholdt SM, Peters RJG, Hack CH, Day NE, Luben R, Bingham SA, Wareham NJ, Reitsma P, Khaw KT. IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: The EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol 2004;24:1503–8.
  • Fassbender K, Kaptur S, Becker P, Groschl J, Hennerici M. Adhesion molecules in tissue injury: kinetics of expression and shedding and association with cytokine release in humans. Clin Immunol Immunopathol 1998;98:54–60.
  • Mayadas TN, Johnson RC, Rayburn H, Hynes RO, Wagner DD. Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell 1993;74: 541–54.
  • Hao JL, Suzuki K, Lu Y, Hirano S, Fukuda K, Kumagai N, Kimura K, Nishida T. Inhibition of gap junction-mediated intercelluler communication by TNF-alpha in cultured human corneal fibroblasts. Invest Opthalmol Vis Sci 2005;46:1195–200.
  • Kazmi SSH, Stranden E. Pathophysiological aspects of lower limb oedema in patients with proximal femoral fractures. Scand J Clin Lab Invest 2009;69:741–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.